HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology
June 16, 2024 20:00 ET | HUTCHMED (China) Limited
— Publication shows treatment demonstrated durable response rate of 48.4% vs. 0% with placebo — — Presentations at EHA showcased subgroup analyses demonstrating consistent benefits regardless of...
KE Holdings Inc. Announces Results of Annual General Meeting
June 14, 2024 09:20 ET | KE Holdings Inc.
BEIJING, June 14, 2024 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), a leading integrated online and offline platform for housing transactions and...
junshi-topalliance-logo.png
Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint
June 11, 2024 22:06 ET | Junshi Biosciences
SHANGHAI, June 11, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to...
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China
June 06, 2024 20:00 ET | HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I...
NIO Inc. Reports Unaudited First Quarter 2024 Financial Results
June 06, 2024 06:10 ET | NIO Inc.
SHANGHAI, June 06, 2024 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today...
GDS to Hold Annual General Meeting on June 27, 2024
June 03, 2024 08:30 ET | GDS Holdings Limited
SHANGHAI, June 03, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers...
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
June 02, 2024 20:00 ET | HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that results from FRUTIGA,...
NIO Inc. Provides May 2024 Delivery Update
June 01, 2024 05:30 ET | NIO Inc.
NIO delivered 20,544 vehicles in May 2024, increasing by 233.8% year-over-yearNIO delivered 66,217 vehicles year-to-date in 2024, increasing by 51.0% year-over-year Cumulative deliveries of NIO...
XPENG.jpg
XPENG Announces Vehicle Delivery Results for May 2024
June 01, 2024 05:00 ET | XPeng Inc.
GUANGZHOU, China, June 01, 2024 (GLOBE NEWSWIRE) -- XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced...
Li Auto Inc. May 2024 Delivery Update
May 31, 2024 22:00 ET | Li Auto Inc.
BEIJING, June 01, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company...